The NeurologyLive® MS Disease Spotlight page offers specific updates and coverage on the latest expert conversations and data readouts related to the treatment and management of patients with multiple sclerosis and demyelinating disorders.
Disproportionate Neurodegeneration in Black Patients With MS: The Need for Stratified Treatments
November 28th 2021Identifying the best treatment strategy for Black or African American patients who are at risk for a more challenging clinical course is of great importance and represents a key unmet need in our field.
Advanced Practice Providers’ Perspectives on Optimal Multiple Sclerosis Management
November 25th 2021In a NeurologyLive® Peer Exchange series, experts on the care of patients with multiple sclerosis offer recommendations for selecting and sequencing therapies used to treat patients with relapsing disease.
Realistic Outlook for Mesenchymal Stem Cells, Other Treatments in Progressive MS: Jeffrey Cohen, MD
November 22nd 2021The director of the Mellen Center for MS Treatment and Research at Cleveland Clinic discussed when clinicians should anticipate new therapies to treat progressive MS. [WATCH TIME: 2 minutes]
Incorporation of Registered Dietitians in MS Care: Tyler Titcomb, PhD, RDN, IFMCP
November 18th 2021The postdoctoral scholar at the University of Iowa commented on why the multiple sclerosis field should lean on registered dietitians to help alleviate symptoms of patients with multiple sclerosis. [WATCH TIME: 2 minutes]
Therapeutic Approaches to Fatigue in Multiple Sclerosis: Anna Kratz, PhD
November 17th 2021Discussing cognitive behavioral therapy for patients with MS, the associate professor of Physical Medicine and Rehabilitation and research nonclinical psychologist at the University of Michigan Medicine mentioned different therapeutic options that can benefit this patient population. [WATCH TIME: 3 minutes]
Why MS Clinicians Should Care More About Diet: Tyler Titcomb, PhD, RDN, IFMCP
November 17th 2021The postdoctoral scholar at the University of Iowa discussed the importance of understanding more about the effects of diet and how it is managed when caring for a patient with multiple sclerosis. [WATCH TIME 3 minutes]
Anna Kratz, PhD, on Managing MS Fatigue in a Multifaceted Way
November 16th 2021Anna Kratz, PhD, associate professor of Physical Medicine & Rehabilitation, University of Michigan Medicine, spoke to the benefits of a multifaceted approach to managing fatigue for patients with multiple sclerosis.
Strategies, Tools for Treating Fatigue in Multiple Sclerosis: Anna Kratz, PhD
November 16th 2021The associate professor of Physical Medicine & Rehabilitation and research nonclinical psychologist at the University of Michigan Medicine discussed challenges when addressing fatigue, as well as the need to integrate digital tools for patients with MS. [WATCH TIME: 4 minutes]
A Multidisciplinary Approach to Fatigue in Multiple Sclerosis: Anna Kratz, PhD
November 14th 2021The associate professor of Physical Medicine & Rehabilitation and nonclinical research psychologist at University of Michigan Medicine discussed the complexities of fatigue as a symptom following her presentation at CMCS 2021.
Designing an MS Clinical Trial Focused on Minority Populations: Mitzi Joi Williams, MD
November 11th 2021Outlining the development of the CHIMES trial in multiple sclerosis, the founder and CEO of Joi Life Wellness Group Multiple Sclerosis Center spoke on tactics to get underrepresented populations involved. [WATCH TIME: 2 minutes]
Quality of Life Improvements in MS Following Wellness Program: Brian Hutchinson, PT, MSCS
November 8th 2021The director of the Multiple Sclerosis Achievement Center in Sacramento discussed 3-year data from an assessment of the program, outlining key findings and future research efforts. [WATCH TIME: 6 minutes]
Discussing COVID-19 Vaccinations and Disease-Modifying Therapies in Multiple Sclerosis
November 4th 2021Amit Bar-Or, MD, FRCPC, FAAN, FANA, commented on his presentations at CMSC 2021, one of which focused on COVID-19 vaccination, which experts do not believe poses risks for those on disease-modifying therapies.
Greater Health Inequities, Disparities in Demyelinating Disease Identified
October 12th 2021Investigators highlighted the need to integrate research frameworks to analyze and understand these interrelationships, developing appropriate interventions for the Black, Latinx, and Hispanic populations with NMOSD and MS.
Differences in Care for Millennial Patients With MS: Mitzi Joi Williams, MD
September 30th 2021As the MS patient population includes more patients from the millennial generation, the founder and CEO of the Joi Life Wellness Group Multiple Sclerosis Center offered her insight on the way care differs for this generation compared with prior ones. [WATCH TIME: 4 minutes]
Effective Comprehensive Care Team Communication in MS: Patricia Bobryk, MHS, PT, MSCS, ATP
September 30th 2021The physical therapist at UC Health and cochair of the International Organization of MS Rehabilitation Therapists discussed the importance of the care team for patients with MS and the role effective communication plays. [WATCH TIME: 4 minutes]
EvoWalk Digital Therapy Platform Pilot Program Launched by Evolution Devices
September 21st 2021Lisa Donahue PT, MPT, NCS, the director of Clinical Services at Evolution Devices, offered details about the EvoWalk platform, its potential in neurorehabilitation efforts, and its future clinical availability.
The Critical Nature of Patient-Focused MS Care: Patricia Bobryk, MHS, PT, MSCS, ATP
September 15th 2021With the field of multiple sclerosis care focusing on the importance of patient-reported outcomes and shared decision-making, the physical therapist at UC Health and cochair of the International Organization of MS Rehabilitation Therapists offered commentary.
The Availability of MS Rehabilitation Therapists: Patricia Bobryk, MHS, PT, MSCS, ATP
September 13th 2021Amid an ongoing national shortage of clinicians who treat neurologic diseases like MS, the cochair of the International Organization of MS Rehabilitation Therapists discussed the availability of rehabilitation professionals for patients.
Early Intervention With Physical Therapy for MS: Patricia Bobryk, MHS, PT, MSCS, ATP
September 12th 2021The physical therapist at UC Health and cochair of the International Organization of MS Rehabilitation Therapists spoke to the current standards of rehabilitative care among patients with multiple sclerosis.
Cutting Edge Care in Multiple Sclerosis: Advances in S1P Therapy
July 28th 2021Jessica L. Stulc, MD, MPH, offered an in-depth review of the latest approved therapies in the sphingosine phosphate 1 targeting class of oral medications for MS including ozanimod (Zeposia; BMS) and ponesimod (Ponvory; Janssen).
Biogen and InnoCare Reach Collaboration Agreement for BTK Inhibitor Orelabrutinib
July 18th 2021Orelabrutinib has the potential to inhibit B cell and myeloid cell effector functions in the central nervous system and may provide a clinically meaningful benefit on progression in all forms of MS.
Atrophied Lesion Volume as a Biomarker of Disability in Progressive Multiple Sclerosis
June 29th 2021Robert Zivadinov, MD, PhD, director, Buffalo Neuroimaging Analysis Center, spoke to the findings of a post-hoc analysis of atrophied T2-lesion volume as a biomarker in patients with progressive MS.
MRI in Multiple Sclerosis Guidelines Update: North America, Europe Align on New Recommendations
June 15th 2021These consensus guidelines are significant not only for their key updates to clinical practice but for their representation of a more unified, global approach to diagnosing and monitoring patients with multiple sclerosis.
What Role Does Age Play in Multiple Sclerosis?
April 15th 2020The director of the Multiple Sclerosis Program at Cleveland Clinic Lou Ruvo Center for Brain Health discussed the correlation between age and disease duration in MS, as well as what was learned from a subanalysis of the EXPAND study of siponimod.